$东阳光长江药业(0_老虎社区_美港股上老虎

谈今论股
12:57

$东阳光长江药业(01558)$ 吸收合并方案提供19.3港元换股溢价（较现价隐含空间30%+），叠加1.5港元特别股息，短期安全边际明确。中长期看，GLP-1双抗9.38亿美元BD协议打开全球减重市场，胰岛素产品收入翻倍，创新药管线估值尚未充分计价。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":438310754033672,"tweetId":"438310754033672","gmtCreate":1747976253932,"gmtModify":1747976255369,"author":{"id":4107612084981750,"idStr":"4107612084981750","authorId":4107612084981750,"authorIdStr":"4107612084981750","name":"谈今论股","avatar":"https://static.tigerbbs.com/59ec5fb35863484255ebc8aebe767f64","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>吸收合并方案提供19.3港元换股溢价（较现价隐含空间30%+），叠加1.5港元特别股息，短期安全边际明确。中长期看，GLP-1双抗9.38亿美元BD协议打开全球减重市场，胰岛素产品收入翻倍，创新药管线估值尚未充分计价。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>吸收合并方案提供19.3港元换股溢价（较现价隐含空间30%+），叠加1.5港元特别股息，短期安全边际明确。中长期看，GLP-1双抗9.38亿美元BD协议打开全球减重市场，胰岛素产品收入翻倍，创新药管线估值尚未充分计价。</p></body></html>","text":"$东阳光长江药业(01558)$ 吸收合并方案提供19.3港元换股溢价（较现价隐含空间30%+），叠加1.5港元特别股息，短期安全边际明确。中长期看，GLP-1双抗9.38亿美元BD协议打开全球减重市场，胰岛素产品收入翻倍，创新药管线估值尚未充分计价。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/438310754033672","repostId":0,"isVote":1,"tweetType":1,"viewCount":382,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01558"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":210,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}